Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Non-cash Items (2018 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Non-cash Items for 9 consecutive years, with $1.7 million as the latest value for Q1 2026.

  • For Q1 2026, Non-cash Items fell 71.74% year-over-year to $1.7 million; the TTM value through Mar 2026 reached $1.7 million, down 71.74%, while the annual FY2025 figure was $6.6 million, 30.53% down from the prior year.
  • Non-cash Items hit $1.7 million in Q1 2026 for Bicycle Therapeutics, down from $2.7 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $130.4 million in Q1 2022 and bottomed at $1.7 million in Q1 2026.
  • Average Non-cash Items over 5 years is $25.7 million, with a median of $6.3 million recorded in 2025.
  • On a YoY basis, Non-cash Items climbed as much as 6362.45% in 2022 and fell as far as 97.5% in 2022.
  • Bicycle Therapeutics' Non-cash Items stood at $71.0 million in 2022, then plummeted by 69.13% to $21.9 million in 2023, then crashed by 56.39% to $9.6 million in 2024, then tumbled by 71.96% to $2.7 million in 2025, then tumbled by 36.49% to $1.7 million in 2026.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $1.7 million, $2.7 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.